Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Prostate
Study Phase
Phase 3
Study Completion Date
May 2008
NCT00089674Uploaded 09-26-2016
Available for Download
PDS UID: Prostat_Amgen_2004_154
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer
Files:
PROTOCOL20040138 Protocol Amend 5 REDACTED.pdf
CRFAmgen 20040138 CRF REDACTED.pdf
DATA DICTIONARYAmgen 20040138 DDT.pdf
DATA (COMPARATOR ARM)Amgen 20040138 SAS datasets.zip